Immunotherapeutic polypeptide agents which bind to lymphocyte im

Details Immunotherapeutic polypeptide agents which bind to lymphocyte im Immunotherapeutic polypeptide agents which bind to lymphocyte im

1983-08-12

1987-07-28

Phillips, Delbert R.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

8 to 10 amino acid residues in defined sequence

C07K 706

Patent

active

046832920

ABSTRACT:
An active site peptide which blocks immune complex binding to Fc receptors, the peptide having an amino acid sequence selected from the group consisting of:

REFERENCES:
patent: 3778426 (1973-12-01), Najjar
patent: 4153688 (1979-05-01), Dimicoli et al.
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4201770 (1980-05-01), Stevens
patent: 4215112 (1980-07-01), Goldstein et al.
patent: 4223016 (1980-09-01), Roy et al.
patent: 4225579 (1980-09-01), Kleinberg
patent: 4284537 (1981-08-01), Beachey
patent: 4341755 (1982-07-01), Lindall
patent: 4369138 (1983-01-01), Lindall
patent: 4388233 (1983-06-01), Bissell et al.
patent: 4407948 (1983-10-01), Goodman et al.
patent: 4409141 (1983-10-01), Noda et al.
patent: 4409144 (1983-10-01), Heinicke
patent: 4415493 (1983-11-01), Weigle et al.
patent: 4436874 (1984-03-01), Aspisi et al.
patent: 4454121 (1984-06-01), Beachey
patent: 4457867 (1984-07-01), Ishida
patent: 4474757 (1984-10-01), Arnon et al.
patent: 4476116 (1984-10-01), Anik
patent: 4497801 (1985-02-01), Hashimoto et al.
Proc. Nat. Acad. Sci., vol. 72, No. 6, pp. 2081-2083 (1975).
Molecular Immunology, vol. 19, No. 10, pp. 1245-1254 (1982).
Science, (1975) pp. 389-390, vol. 189.
Veretennikova et al., Int. J. Peptide Protein Res. 17, (1981) 430-435.
Plummer, et al., Fed. Proc. 42 713 (1983).
Hunninghake et al. Clin. Immunol Rev. 1 (3) 337 (1981-1982).
Hunsicker, J. Exp. Med. 150 413 (1979).
Johnson et al., (J. Immunol., 117, 1491 (1975)).
Boackle et al., (Nature, 282, 742 (1979)).
Prystowksy et al. (Biochemistry 20, 6349 (1981)).
Lukas et al. (J. Immunol. 127, 2555 (1981)).
Burton et al. Nature 288, 338 (1980).
Morgan et al. (Proc. Natl. Acad. Sci. USA 79, 5388 (1982)).
Ciccimarra et al. (Proc. Natl. Acad. Sci. USA 72 208 (1975)).
Stanworth Mol. Immunol. 19 1245 (1982).
Hamburger, Immunology 38, 78 (1979).
Biochem, J., 180 665 (1979).
Biochem, J., 181 623 (1979).
Barnett-Foster et al. Mol. Immunol 19 407 (1982).
Barnett-Foster et al. J. Immunol 120, 407 (1978).
Takatsu et al., J. Immunol 114 1838 (1975).
Dorrington et al. Immunol Rev. 41, 3 (1978).
Perex-Montfort Mol. Immunol 19 1113 (1982).
Kuehl et al. Science 210 978 (1980).
Goodwin Clin, Immunol Immunopath 15 106 (1980).
Stenson et al. Immunol 125 1 (1980).
Leung et al. J. Immunol 129 1742 (1982).
Fischer et al. J. Immunol 126 1452 (1981).
Klein et al. Immunol 48 337 (1983).
Goodwin et al. Cancer Immunol Immunother., 8, 3 (1980).
Samuelsson Science 220 568 (1983).
Weiss et al. J. Immunol 129 309 (1982).
Fantone, J. Pathol. 107 397 (1982).
Perex et al. Textbook Rheumatogoly, vol. 1, W. B. Saunders Philadelphia, 1981 pp. 179-194).
Dreisn et al. N. Engl. J. Med. 298 358 (1978).
Lawrence et al. N. Engl. J. Med. 302 1187 (1980).
Holdsworth J. Immunol 130 735 (1983).
Striker J. Exp. Med. 149, 127 (1979).
Kumar in Pathologic Basis of Disease eds. S. L. Robbins & R. S. Cotran (W. B. Saunders; Philadelphia, 1979), p. 304.
Melwicz et al., Clin. Exp. Immunol., 49, 364 (1982).
Spiegelberg, et al., 42, 124 (1983).
Scott et al., Fed. Proc., 42, 129 (1983).
McMillan, N. Engl. J. Med., 304, 1135 (1981).
Fehr et al. (N. Engl. J. Med., 306, 1254 (1982)).
Imbach et al. (Lancet, Jun. 6, 1981, p. 1228).
Oberbarnscheidt et al., Immunol., 35, 151 (1978).
Kolsch et al., Immunol. Rev., 49, 61 (1980).
Fridman et al., Immunol Rev. 56, 51 (1981).
Bich-Thuy, J. Immunol., 129, 150 (1982).
Smolen et al., J. Immunol., 129, 10150 (1982).
Goeken et al. Hum. Immunol., 6, 79 (1983).
Kabelitz et al., Eur. J. Immunol., 12, 687 (1982).
Sakane et al., Proc. Natl. Acad. Sci. U.S.A., 75, 3464 (1978).
Miyasaka et al., J. Clin. Invest., 66, 928 (1980).
James et al., J. Clin. Invest., 66, 1305 (1980).
Hodgkin's Lymphoma (Engleman, et al., J. Clin. Invest., 66 149 (1980).
Smith et al. J. Natl. Cancer Inst., 58, 579 (1977).
Cochrane et al., Lancet 1, 441 (1976).
Douvas, Ann. Immunol. Inst. Pasteur, 132C, 307 (1981).
Ulcerative colitis (Hibi, et al., Clin. Exp. Immunol. 49, 75 (1982)).
Hashimoto's thyroiditis (Calder et al., Clin. Exp. Immunol., 14, 153 (1973)).
Gonzalez-Molina et al., J. Clin. Invest., 59, 616 (1977).
Merrifield J. Am. Chem Soc., 85, 2149-2154 (1963).
Barany & Merrifield in The Peptides eds. E. Gross & F. Meinehofer, vol. 2 (Academic Press, 1980) pp. 2 285.
Synthesis of a Tetrapeptide by R. B. Merrifield, Journal of American Chemical Society (vol. 85, pp. 85, pp. 2 2154 (1963)).

Affiliated with

Also associated with

Rating

Immunotherapeutic polypeptide agents which bind to lymphocyte im does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutic polypeptide agents which bind to lymphocyte im, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic polypeptide agents which bind to lymphocyte im will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2035392